Pieris Pharmaceuticals Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Red day on Friday for Pieris Pharmaceuticals
(Updated on May 03, 2024)
The Pieris Pharmaceuticals stock price fell by -1.42% on the last day (Friday, 3rd May 2024) from $11.24 to $11.08. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.66% from a day low at $10.60 to a day high of $11.20. The price has fallen in 6 of the last 10 days but is still up by 7541.38% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -50 thousand shares and in total, 31 thousand shares were bought and sold for approximately $345.80 thousand.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $13.07 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 172.62% during the next 3 months and, with a 90% probability hold a price between $3.67 and $35.63 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PIRS Signals & Forecast
The Pieris Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $11.53. On a fall, the stock will find some support from the long-term average at approximately $3.12. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -7.67%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Pieris Pharmaceuticals stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.600 between high and low, or 5.66%. For the last week the stock has had daily average volatility of 4.62%.
The Pieris Pharmaceuticals stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stop-loss: $10.53 (-5.00%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 92 and this increases the risk substantially. There is a sell signal from a pivot top found 8 days ago.)
Trading Expectations (PIRS) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Pieris Pharmaceuticals to open at $10.96, and during the day (based on 14 day Average True Range), to move between $10.32 and $11.84, which gives a possible trading interval of +/-$0.763 (+/-6.89%) up or down from last closing price. If Pieris Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 13.77% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $11.24, some $0.160 (1.44%) from the current price of $11.08, our system finds the risk reward not very attractive.
Earnings coming up
Pieris Pharmaceuticals will release earnings BMO on Wednesday, May 08, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.120. We will update the financials statements for Pieris Pharmaceuticals, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 13.66% in the first trading day after earnings release.
Is Pieris Pharmaceuticals stock A Buy?
Pieris Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: -0.429 Hold/Accumulate Unchanged
Predicted Opening Price for Pieris Pharmaceuticals of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $10.96 ( 1.08%) | $11.08 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PIRS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 11.56 | 4.33 % | |
| R2 | 11.33 | 2.26 % | ||
| R1 | 11.19 | 0.99 % | ||
| Current price: | 11.08 | |||
| Support | S1 | 10.73 | -3.15 % | |
| S2 | 10.59 | -4.43 % | ||
| S3 | 10.36 | -6.50 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 12.00 | 8.30 % | |
| R2 | 11.68 | 5.42 % | ||
| R1 | 11.24 | 1.44 % | ||
| Current price | 11.08 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Pieris Pharmaceuticals Stock.
